-
(106-16) A Pilot Multi-Arm Study of sEphB4-HSA In Combination with Different
Chemotherapy Regimens in Patients with Specific Advanced or Metastatic
Solid Tumors (Phase 1 clinical trial, appropriate for patients with metastatic cancers
of the bile duct, gallbladder; head and neck; non-small cell lung; and
pancreas.)
-
(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6
in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
-
(134-17) A Phase IIa trial of sEphB4-HSA in combination with Anti PD-1
Antibody (Pembrolizumab, MK-3475) in patients with non-small cell lung
and head/neck cancer (Phase 2 clinical trial, appropriate for patients with lung, head or neck cancer.)
-
(155-17) 0C 17-1: Phase 1 Multi-center Study of the Safety Pharmacokinetics
and Preliminary Efficacy of CBT-101 in Subjects with Advanced Solid Tumors
and C-Met Dysregulation (Phase 1 clinical trial, appropriate for patients with advanced solid
malignancies.)
-
(211-17) An Open-Label, Non-Randomized, Multicenter Study to Determine
the Pharmacokinetics and Safety of Niraparib Following A Single Oral Dose
in Patients with Advanced Solid Tumors and Either Normal Hepatic Function
or Moderate Hepatic Impairment (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
-
(214-17) A Phase 1/2 First-in-human Study of BMS-986258 Alone and in Combination
with Nivolumab in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)